Compare $ERNA vs $PMCB | Chartloom

Compare

$ERNA vs $PMCB

Ernexa Therapeutics Inc · PharmaCyte Biotech Inc

ERNA

Ernexa Therapeutics Inc

PMCB

PharmaCyte Biotech Inc

Compare $ERNA vs $PMCB

Comparing Ernexa Therapeutics Inc and PharmaCyte Biotech Inc

ERNAErnexa Therapeutics Inc

PMCBPharmaCyte Biotech Inc

ERNAErnexa Therapeutics Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-91.7%

52W performance

-93.0%

FCF yield

-316.2%

PMCBPharmaCyte Biotech Inc

Market cap

$4M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-45.2%

52W performance

-60.4%

FCF yield

-90.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ERNA

PMCB

Detailed metrics comparison

ERNA

Ernexa Therapeutics Inc

PMCB

PharmaCyte Biotech Inc

Market Cap

ERNA$3M

PMCB$4M

Enterprise Value

ERNA$-2M

PMCB$-13M

Price

ERNA$2.40

PMCB$0.40

P/E Ratio

ERNAN/A

PMCBN/A

P/S Ratio

ERNA8.30x

PMCB107.65x

EV/Sales

ERNA0.09x

PMCB-336.93x

EV/EBITDA

ERNA0.00x

PMCB0.00x

P/B Ratio

ERNA1.51x

PMCB0.14x

P/FCF Ratio

ERNAN/A

PMCBN/A

EV/FCF

ERNA0.22x

PMCB3.40x

PEG Ratio

ERNAN/A

PMCBN/A

Forward P/E (NTM)

ERNAN/A

PMCBN/A

Forward P/S (NTM)

ERNAN/A

PMCBN/A

Revenue (TTM)

ERNA$0

PMCB$0

Revenue Growth (YoY)

ERNAN/A

PMCBN/A

Forward Rev Growth

ERNA0.0%

PMCB0.0%

Gross Margin (TTM)

ERNA83.5%

PMCB81.7%

Operating Margin (TTM)

ERNA0.0%

PMCB0.0%

EBITDA Margin (TTM)

ERNA0.0%

PMCB0.0%

Net Margin (TTM)

ERNA0.0%

PMCB0.0%

FCF Margin (TTM)

ERNAN/A

PMCBN/A

Net Income (TTM)

ERNA$-3M

PMCB$-21M

FCF (TTM)

ERNA$-9M

PMCB$-4M

EPS (TTM)

ERNA$0.00

PMCB-$1.92

ROE (TTM)

ERNA-16940.0%

PMCB-4588.0%

ROA (TTM)

ERNA-22854.0%

PMCB-3307.0%

ROIC (TTM)

ERNA-15802.0%

PMCB-4588.0%

Cash

ERNA$5M

PMCB$18M

Debt

ERNA$250K

PMCB$0

Net Cash/Debt

ERNA$5M

PMCB$18M

Current Ratio (TTM)

ERNA2.01x

PMCB40.30x

Quick Ratio (TTM)

ERNA1.74x

PMCB40.25x

Debt/Equity (TTM)

ERNA0.08x

PMCB0.00x

Debt/Assets (TTM)

ERNA0.0%

PMCB0.0%

Interest Coverage (TTM)

ERNAN/A

PMCBN/A

Net Debt/EBITDA (TTM)

ERNA0.00x

PMCB0.00x

Beta

ERNA2.68

PMCB0.74

52W Performance

ERNA-93.0%

PMCB-60.4%

YTD Performance

ERNA-91.7%

PMCB-45.2%

% from 52W High

ERNA-96.6%

PMCB-73.2%

% from 52W Low

ERNA13.2%

PMCB21.1%

Asset Turnover (TTM)

ERNA0.02x

PMCB0.02x

FCF Yield (TTM)

ERNA-316.2%

PMCB-90.7%

Earnings Yield (TTM)

ERNA-97.9%

PMCB-475.0%

Dividend Yield (TTM)

ERNA0.4%

PMCBN/A

Rule of 40

ERNA0.0

PMCB0.0

EV/GP/RG

ERNAN/A

PMCBN/A

Ticker research

View ERNA research View PMCB research

Metric	ERNA Ernexa Therapeutics Inc	PMCB PharmaCyte Biotech Inc
Market & Valuation
Market Cap	$3M	$4M
Enterprise Value	$-2M	$-13M
Price	$2.40	$0.40
P/E Ratio	N/A	N/A
P/S Ratio	8.30x	107.65x
EV/Sales	0.09x	-336.93x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.51x	0.14x
P/FCF Ratio	N/A	N/A
EV/FCF	0.22x	3.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	83.5%	81.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-3M	$-21M
FCF (TTM)	$-9M	$-4M
EPS (TTM)	$0.00	-$1.92
ROE (TTM)	-16940.0%	-4588.0%
ROA (TTM)	-22854.0%	-3307.0%
ROIC (TTM)	-15802.0%	-4588.0%
Financial Health
Cash	$5M	$18M
Debt	$250K	$0
Net Cash/Debt	$5M	$18M
Current Ratio (TTM)	2.01x	40.30x
Quick Ratio (TTM)	1.74x	40.25x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.68	0.74
52W Performance	-93.0%	-60.4%
YTD Performance	-91.7%	-45.2%
% from 52W High	-96.6%	-73.2%
% from 52W Low	13.2%	21.1%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.02x
FCF Yield (TTM)	-316.2%	-90.7%
Earnings Yield (TTM)	-97.9%	-475.0%
Dividend Yield (TTM)	0.4%	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ERNA research	View PMCB research

Valuation

P/S Ratio

ERNA

8.30x

PMCB

107.65x

EV/FCF

ERNA

0.22x

PMCB

3.40x

Growth & revenue

Forward Revenue Growth

ERNA

0.0%

PMCB

0.0%

Profitability & performance

Gross Margin

ERNA

83.5%

PMCB

81.7%

ROE

PMCB

-4588.0%

ERNA

-16940.0%

FCF Yield %

PMCB

-90.7%

ERNA

-316.2%

52-Week Performance

PMCB

-60.4%

ERNA

-93.0%

Detailed metrics comparison

ERNA

Ernexa Therapeutics Inc

PMCB

PharmaCyte Biotech Inc

Market Cap

ERNA$3M

PMCB$4M

Enterprise Value

ERNA$-2M

PMCB$-13M

Price

ERNA$2.40

PMCB$0.40

P/E Ratio

ERNAN/A

PMCBN/A

P/S Ratio

ERNA8.30x

PMCB107.65x

EV/Sales

ERNA0.09x

PMCB-336.93x

EV/EBITDA

ERNA0.00x

PMCB0.00x

P/B Ratio

ERNA1.51x

PMCB0.14x

P/FCF Ratio

ERNAN/A

PMCBN/A

EV/FCF

ERNA0.22x

PMCB3.40x

PEG Ratio

ERNAN/A

PMCBN/A

Forward P/E (NTM)

ERNAN/A

PMCBN/A

Forward P/S (NTM)

ERNAN/A

PMCBN/A

Revenue (TTM)

ERNA$0

PMCB$0

Revenue Growth (YoY)

ERNAN/A

PMCBN/A

Forward Rev Growth

ERNA0.0%

PMCB0.0%

Gross Margin (TTM)

ERNA83.5%

PMCB81.7%

Operating Margin (TTM)

ERNA0.0%

PMCB0.0%

EBITDA Margin (TTM)

ERNA0.0%

PMCB0.0%

Net Margin (TTM)

ERNA0.0%

PMCB0.0%

FCF Margin (TTM)

ERNAN/A

PMCBN/A

Net Income (TTM)

ERNA$-3M

PMCB$-21M

FCF (TTM)

ERNA$-9M

PMCB$-4M

EPS (TTM)

ERNA$0.00

PMCB-$1.92

ROE (TTM)

ERNA-16940.0%

PMCB-4588.0%

ROA (TTM)

ERNA-22854.0%

PMCB-3307.0%

ROIC (TTM)

ERNA-15802.0%

PMCB-4588.0%

Cash

ERNA$5M

PMCB$18M

Debt

ERNA$250K

PMCB$0

Net Cash/Debt

ERNA$5M

PMCB$18M

Current Ratio (TTM)

ERNA2.01x

PMCB40.30x

Quick Ratio (TTM)

ERNA1.74x

PMCB40.25x

Debt/Equity (TTM)

ERNA0.08x

PMCB0.00x

Debt/Assets (TTM)

ERNA0.0%

PMCB0.0%

Interest Coverage (TTM)

ERNAN/A

PMCBN/A

Net Debt/EBITDA (TTM)

ERNA0.00x

PMCB0.00x

Beta

ERNA2.68

PMCB0.74

52W Performance

ERNA-93.0%

PMCB-60.4%

YTD Performance

ERNA-91.7%

PMCB-45.2%

% from 52W High

ERNA-96.6%

PMCB-73.2%

% from 52W Low

ERNA13.2%

PMCB21.1%

Asset Turnover (TTM)

ERNA0.02x

PMCB0.02x

FCF Yield (TTM)

ERNA-316.2%

PMCB-90.7%

Earnings Yield (TTM)

ERNA-97.9%

PMCB-475.0%

Dividend Yield (TTM)

ERNA0.4%

PMCBN/A

Rule of 40

ERNA0.0

PMCB0.0

EV/GP/RG

ERNAN/A

PMCBN/A

Ticker research

View ERNA research View PMCB research

Metric	ERNA Ernexa Therapeutics Inc	PMCB PharmaCyte Biotech Inc
Market & Valuation
Market Cap	$3M	$4M
Enterprise Value	$-2M	$-13M
Price	$2.40	$0.40
P/E Ratio	N/A	N/A
P/S Ratio	8.30x	107.65x
EV/Sales	0.09x	-336.93x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.51x	0.14x
P/FCF Ratio	N/A	N/A
EV/FCF	0.22x	3.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	83.5%	81.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-3M	$-21M
FCF (TTM)	$-9M	$-4M
EPS (TTM)	$0.00	-$1.92
ROE (TTM)	-16940.0%	-4588.0%
ROA (TTM)	-22854.0%	-3307.0%
ROIC (TTM)	-15802.0%	-4588.0%
Financial Health
Cash	$5M	$18M
Debt	$250K	$0
Net Cash/Debt	$5M	$18M
Current Ratio (TTM)	2.01x	40.30x
Quick Ratio (TTM)	1.74x	40.25x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.68	0.74
52W Performance	-93.0%	-60.4%
YTD Performance	-91.7%	-45.2%
% from 52W High	-96.6%	-73.2%
% from 52W Low	13.2%	21.1%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.02x
FCF Yield (TTM)	-316.2%	-90.7%
Earnings Yield (TTM)	-97.9%	-475.0%
Dividend Yield (TTM)	0.4%	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ERNA research	View PMCB research